Affymax Reviews

8 Reviews
3.7
8 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Affymax CEO and Director John Orwin
John Orwin
1 Rating
  1.  

    Great place to work, but didn't focus enough on pipeline for future

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Former Employee - Affymax in Palo Alto, CA (US)
    Former Employee - Affymax in Palo Alto, CA (US)

    I worked at Affymax as a contractor (less than an year)

    Pros

    great co-workers and management. also great culture and work/life balance

    Cons

    no investment in R&D for future pipeline

    Advice to ManagementAdvice

    focus on the pipeline in the future

    Recommends
    Negative Outlook
    No opinion of CEO

Affymax Interviews

Interview Experience

Interview Experience

0%
0%
100%

Getting an Interview

Getting an Interview

50%
50%

Interview Difficulty

2.5
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Research Associate Interview

    Anonymous Interview Candidate
    Anonymous Interview Candidate
    Application Details

    I applied online. The process took a dayinterviewed at Affymax.

    Interview Details

    All day interview with 8 scientists and 4 technicians. Thorough assessment of all technical skills and academic experience. Very attentive audience at presentation with insightful questions. Beautiful facilities and support services. Supervisor stressed intellectual-minded faculty and opportunity to conduct self-directed research.

    Interview Questions
    • How have you demonstrated ability to solve difficult problems in the lab and with other scientists?   Answer Question
    Accepted Offer

Affymax Awards and Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.affymax.com
Headquarters Palo Alto, CA
Size 16 to 50 Employees
Founded 2001
Type Company - Public
Industry Biotech & Pharmaceuticals
Revenue ₹100 to ₹500 million (INR) per year
Competitors Amgen, Janssen Biotech, Roche

Affymax is designing peptides to give red blood cells a pep talk. The biotechnology firm is researching and developing possible drugs based upon these biological process regulators. Its leading drug candidate, Hematide, is an erythropoietin (EPO) mimetic, designed to stimulate red blood cell production, like EPO itself. Hematide is being investigated in late stage clinical trials as a possible treatment for anemia caused by chronic renal failure and chemotherapy. Affymax believes Hematide will be cheaper and longer lasting than the EPO stimulants currently used on dialysis... More

Work at Affymax? Share Your Experiences

Affymax

 
Click to Rate
or